The renal and urologic complications of Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Volumn 3, Issue 3, 1997, Pages 217-224

  El Serag, Hashem B ^a,e   Zwas, Felice ^a,d   Bonheim, Nelson A ^a   Cirillo, Nicholas W ^b   Appel, Gerald ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Wilkes Regional Medical Center   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d University of New Mexico ^*  (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Complications; Genitourinary system; Renal system

Indexed keywords

EID: 27644519344     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199709000-00006     Document Type: Review

References (71)

1. Shield DE, Lytton B, Weiss RM, et al. Urologic complications of inflammatory bowel disease. J Urol 1976;115:701-6.
2. Gelzayd EA, Breuer RI, Kirsner JB. Nephrolithiasis in inflammatory bowel disease. Am J Dig Dis 1968;13:1027-34.
3. Preminger GM. Renal calculi: pathogenesis, diagnosis, and medical therapy. Semin Nephrol 1992;12:200-16.
4. Earnest DL, Williams JHE, Admirand WH. Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology 1974;66:1114-22.
5. Chadwick VS, Modha R, Dowling RH. Mechanisms for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 1979;289: 172-6.
6. Kirks DR. Lilhiasis due to the interruption of enterohepatic circulation of bile salts. AJR 1979;133:383-8.
7. Ljunghall S, Christensson T, Wengle B. Renal stone disease: studies of epidemiology and calcium metabolism. Scand J Urol Nephrol 1977;41:39-53.
8. Dobbins JW, Binder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med 1977;296:298-301.
9. Kennedy HJ, Fletcher EWL, Truelove SC. Urinary stones in subjects with a permanent ileostomy. Br J Surg 1982;69:661-4.
10. Hylander E, Jarnum S, Frandsen I. Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease. Scand J Gastroenterol 1979;14:475-9.
11. Caudarella R, Rizzoli E, Pironi L, et al. Renal stone formation in patients with inflammatory disease. Scanning Microsc 1993;7: 371-80.
12. Lescovar R, Hartung R, Kratzar M. Bedeutung von Kristallisationsinhibitoren bei der Kalziumlithiasis. Krankenhausarzt 1980;53: 875-9.
13. Rudman D, Dedonis JL, Fountain MT, et al. Hypocitraturia in patients with gastrointestinal absorption. N Engl J Med 1980;303: 657-61.
14. Fukushima T, Yamazaki Y, Sugita A, Tsuchiya S. Prophylaxis of uric acid stone in patients with inflammatory bowel disease following colonic resection. Gastroenterol Jpn 1991;26:430-4.
15. Stelzner M, Phillips JD, Saleh S, et al. Nephrolithiasis and urine ion changes in ulcerative colitis patients undergoing colectomy and endorectal ileal pullthrough. J Surg Res 1990;48:552-56.
16. Wharton R, D'Agati V, Magun M, et al. Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 1990;34:116-21.
17. Hyams JA, Weinberg SR, Alley JL. Chronic ileitis with concomitant ureteritis: case report. Am J Surg 1943;61:117-20.
18. Schoefield PF, Staff WG, Moore T. Ureteral involvement in regional enteritis. J Urol 1986;99:412.
19. Ginzburg L, Oppenheimer GD. Urological complications of regional ileitis. J Urol 1948;59:948-52.
20. Bagby RJ, Clements JL Jr, Patrick JW, et al. Genitourinary complications of granulomatous bowel disease. AJR 1973;117:297-306.
21. Block GE, Enker WE, Kirsner JB. Significance and treatment of occult obstructive uropathy complicating Crohn's disease. Ann Surg 1973;178:322-32.
22. Janowitz HD. Inflammatory bowel disease: personal view. Chicago: Field, Rich and Associates and Yearbook Medical Publishers, 1985:130.
23. Banner MP. Genitourinary complications of inflammatory bowel disease. Radiol Clin North Am 1987;25:199-209.
24. Ten Kate J. Tween Gevallen van Ileitis Terminalis. Nederl Tijdschr Geneesk 1936;80:51.
25. Smith PJB, Williams RE, DeDombal AT. Genitourinary fistulae complicating Crohn's disease. Br J Urol 1972;44:657-61.
26. Greenstein AJ, Sacher DB, Tzakis A, et al. Course of enterovesical fistulas in Crohn's disease. Am J Surg 1984;147:788-92.
27. Goldman SM, Fishman EK, Gatewood OMB, et al. CT in the diagnosis of enterovesical fistula. AJR 1985;144:1229-33.
28. Joffe N. Roentgenologic abnormalities of the urinary bladder secondary to Crohn's disease. Am J Radiol 1976;127:297-302.
29. Amendola MA, Agha FP, Dent TL, et al. Detection of occult colovesical fistula by the Bourne test. Am J Radiol 1984;142: 715-7.
30. Kyle J, Murray CM. Ileovesical fistula in Crohn's disease. Surgery 1969;66:497.
31. Korelitz BI, Adler DJ, Mendelsohn RA, et al. Long term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenrerol 1993;88:1198-205.
32. Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporine A. Am J Gastroenterol 1993;88:646-9.
33. Müller JM, Keller HW, Erasmi H, et al. Total parenteral nutrition as the sole therapy in Crohn's disease - a prospective study. Br J Surg 1983;70:40-3.
34. Oslon ES, Sussman ML. Non-specific enterocolitis. Am J Roentgenol 1948;60:471-91.
35. Gitkind MJ, Wright SC. Amyloidosis complicating inflammatory bowel disease. Dig Dis Sci 1990;35:906-8.
36. Greenstein AJ, Sacher DB, Nannan Pandy AK, et al. Amyloidosis and inflammatory bowel disease, a 50-year experience with 25 patients. Medicine 1992;71:261-70.
37. Lowdell CP, Shousha S, Parkins RA. Incidence of amyloidosis complicating inflammatory bowel disease: a prospective study of 177 patients. Dis Colon Rectum 1986;29:351-4.
38. Shorvon PJ. Amyloidosis and inflammatory bowel disease. Am J Dig Dis 1977;22:209-13.
39. Rand JA, Brandt LJ, et al. Ulcerative colitis complicated by amyloidosis. Am J Gastroenterol 1980;74:185-8.
40. Meyers S, Janowitz HD, et al. Colchicine therapy of renal amyloidosis of ulcerative colitis. Gastroenterology 1988;94:1503-7.
41. Meyers S, Janowitz HD. Complications of Crohn's disease. In: Berk JE, Haubrich WS, Kaiser MH, Roth JLA, Schaffner F, eds. Backus gastroenterology. Philadelphia: WB Saunders, 1985:2294-305.
42. Rashid H, Blake D, Gokal R, et al. The association of renal amyloidosis with regional enteritis (Crohn's disease): report of two cases and review of the literature. Clin Nephrol 1980;14:154-7.
43. Ravid M, Shapira J, Kedar I, et al. Regression of amyloidosis secondary to granulomatous colitis following surgical resection and colchicine administration. Acta Hepatogastroenterol 1979;26: 513-5.
44. Verbanck J, Lameire N, Praet M. Renal amyloidosis as a complication of Crohn's disease. Acta Clin Belg 1979;34:1-13.
45. Fitchen JH. Amyloidosis and granulomatous colitis: regression after surgical removal involved bowel. N Engl J Med 1974;292: 352-5.
46. Mandelstam P, Simmons DE, Mitchell B. Regression of amyloid in Crohn's disease after bowel resection: a 19-year follow-up. J Clin Gastroenterol 1989;11:324-6.
47. Wilcox GM, Aretz T, Roche RK, et al. Glomerulonephritis associated with inflammatory bowel disease. Gastroenterology 1990; 98:786-91.
48. Iida H, Asaka M, Izumino K, et al. IgA nephropathy complicated by ulcerative colitis. Nephron 1984;53:285-6.
49. Makdassy R, Beaufils M, Meyrier A, et al. Pathologic conditions associated with IgA mesangial nephropathy: preliminary results. Contrib Nephrol 1984;40:292-5.
50. Hirsch DJ, Jindall KK, Trillo A, et al. Acute renal failure in Crohn's disease due to IgA nephropathy. Am J Kidney Dis 1992; 20:189-90.
51. Peeters AJ, Van den Wall Bake AWL, Daha MR, Breedveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis and circulating IgA immune complexes. Ann Rheum Dis 1990;49:638-40.
52. Thomas DM, Nicholls AJ, Feest TG. Ulcerative colitis and glomerulonephritis: is there an association? Nephrol Dial Transplant 1990;5:628-9.
53. Hess AD, Esa AH, Colombani PM. Mechanisms of actions of cyclosporine: effect on cells of the immune system and subcelluar events in T cell activation. Transplant Proc 1988;20:29-39.
54. Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995;1:48-63.
55. Lobo AJ, Juby LD, Smith AH, et al. Effect of oral cyclosporine on renal function in Crohn's disease. Dig Dis Sci 1993;38:1624-30.
56. Mihatsch MJ, Thiel G, Ryffel B. Morphology of cyclosporine nephropathy. Prog Allergy 1986;38:447-65.
57. Feutren G, Mihatsch MJ. Committee for the International Kidney Biopsy Registry of Cyclospoine in Autoimmune diseases: risk factors associated for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
58. Sternthal M, George J, Kornbluth A, Lichtiger S, Present D. Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease (IBD) [Abstract]. Gastroenterology 1996;110:A10919.
59. Cockburn ITR, Krupp P. An appraisal of drug interaction with Sandimmune. Transplant Proc 1989;21:3845-50.
60. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 91;3:423-33.
61. Ireland A, Priddle JD, Jewell DP. Acetylation of 5-ASA by isolated human colonic epithelium cells. Clin Sci 1990;78:105-11.
62. Pieniaszek HJ, Bates TR. Capacity limited gut wall metabolism of 5-ASA, therapeutically active metabolite of SZP in rats. J Pharm Sci 1979;68:1323-5.
63. Thulurath PJ, Nikovic M, Calam J, et al. Mesalazine induced interstitial nephritis. Gut 1994;35:1493-6.
64. Dwarakanath AD, Michael J, Allan RN. Sulphasalzine induced renal failure. Gut 1992;33:1006-7.
65. Harbour VM, William PF. Nephrotic syndrome associated with sulphasalazine. BMJ 1990;301:818.
66. Committee on Safety of Medicines. Nephrotoxicity associated with mesalamine: current problems no 30. London: Committee on Safety of Medicines, December 1990.
67. Novis BH, Korzets Z, Chen P, Berheim J. Nephrotic syndrome after treatment with 5-aminosalicylic acid. BMJ 1988;296:1442.
68. Fornaciari G, Maccari S, Borgati PP, Rustichelli R, Amelio N, Lattuada I, Plancher AC. Nephrotic syndrome from 5-ASA for ulcerative colitis? J Clin Gastroenterol 1997;24:37-9.
69. Mahmud N, Stinson J, O'Conell MA, Mantle TJ, Keeling PW, et al. Microalbuminuria in inflammatory bowel disease. Gut 1994; 35:1599-604.
70. Mahmud N, O'Connell MA, Stinson J, Goggin MG, Weir DG. Tumor necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:215-9.
71. Mahmud N, McDonald GS, Kelleher D, Weir DG. Microalbuminuria correlates with intestinal hisopathologic grading in patients with inflammatory bowel disease. Gut 1996;38:99-103.